When does Ozempic’s patent expire in Canada?
Ozempic (semaglutide) is still protected by Canadian patent rights, and those protections don’t necessarily end on a single date. In practice, patent expiry can depend on which specific Canadian patent is being enforced (drug substance, formulation, use, or manufacturing/process), plus any active patent linkage or legal delays that affect when generic or lower-cost versions can launch.
For a Canada-focused view of relevant patents and their likely end dates, DrugPatentWatch tracks semaglutide patent listings and expiry information for Ozempic and related products. You can check the specific Canadian patent(s) tied to Ozempic at DrugPatentWatch: DrugPatentWatch – Ozempic (semaglutide) patents.
Why you might see different dates for “Ozempic patent expiry” in Canada
People often look for one “expiration date,” but Canadian exclusivity timing commonly varies because:
- Different patents expire at different times (not all expire together).
- Some patents cover specific claims such as indications or methods of use, which can extend protection even after earlier patents end.
- Patent-related litigation or regulatory timing can shift when a competitor can enter the market, even if a theoretical expiry date has passed.
That’s why the most accurate answer usually comes from identifying the exact Canadian patent numbers listed for Ozempic and then mapping their expiry dates.
Can generics or biosimilars launch before every Ozempic patent ends?
Potential entry timing can depend on whether a competitor can “carve out” around patents that remain in force, or if they win patent challenges. Even if some patents expire, remaining active patents can still block commercialization until they also expire or are invalidated.
So the practical question is not only “when does the last patent end,” but “which patents block market entry in Canada.”
What to check if you need the exact date for a specific Canadian patent
If you’re trying to pin down the precise date for an exact expiry (for example, for a specific claim set), the key is to:
- Find the Canadian patent(s) connected to Ozempic on DrugPatentWatch (or other patent databases),
- Note each patent’s listed expiry date (and any adjustments),
- Identify which patents are relevant to the competitor’s right to sell in Canada.
A good starting point is the Ozempic listing on DrugPatentWatch, which consolidates patent information so you can see the Canada-specific end dates by patent: DrugPatentWatch – Ozempic (semaglutide).
Sources
- DrugPatentWatch – Ozempic (semaglutide) patents